Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2019) 63 OC1.2 | DOI: 10.1530/endoabs.63.OC1.2

ECE2019 Oral Communications Calcium and Bone (5 abstracts)

Urinary magnesium as predictor of nephrolithiasis in patients with asymptomatic primary hyperparathyroidism

Federica Saponaro 1 , Filomena Cetani 1 , Marina Di Giulio 1 , Francesco Di Giulio 1 , Laura Mazoni 1 , Matteo Apicella 1 , Marco Scalese 2 , Elena Pardi 1 , Simona Borsari 1 & Claudio Marcocci 1

1Endocrinology Unit, University of Pisa, Pisa, Italy; 2Institute of Clinical Physiology, National Council of Research, Pisa, Pisa, Italy.

The 4th International Workshop for the management of asymptomatic PHPT included the presence of hypercalciuria (dUCa> 400 mg/day) and increased stone risk by biochemical stone risk profile as criteria for surgery. Our aim was to evaluate the complete stone risk profile in 176 consecutive patients with asymptomatic PHPT. We recorded clinical and biochemical data, including 24 hours urinary measurements of the following parameters: volume and pH, creatinine, calcium, magnesium, sodium, potassium, ammonium, uric acid, oxalate, citrate, phosphate, inorganic sulphate and chloride and kidney ultrasound. In our cohort dUCa>400 mg/day showed a low sensitivity and positive predictive value (PPV) for nephrolithiasis with high specificity (46.2, 32.7, 73.0% respectively), while hypercalciuria by 4 mg/kg/bw (d-UCa>4 mg/kg) had a high sensibility, with low PPV and specificity (79.5, 27.7, 40.1%). Daily hypomagnesuria (d-HypoMg), but not any other urinary parameter, was an independent predictor of nephrolithiasis in the univariate (OR 2.97 CI 1.27–7.09 P=0.014) and multivariate analyses adjusting for age, sex, BMI, and eGFR (OR 3.13 CI 1.17–8.42 P=0.02). In the regression analyses with urinary calcium d-HypoMg was relatively lower in patients with nephrolithiasis compared with those without. The mean ratio between (dUCa) and (dUMg) was higher in patents with nephrolithiasis compared with those without (4.6±2.0 vs 3.3±4.1; P<0.001). In the univariate and multivariate analyses the dUCa/dUMg ratio was a significant predictor of nephrolithiasis [OR 4.9 (2.3–10.5); P<0.001; OR 5.3 (2.4–11.6), P<0.001, respectively]. The AUC using the dUCa/dUMg ratio as variables was 0.69 (CI 0.60–0.79; P<0.0001). The best cut-off value, set at the highest Youden index, was equal to 4.0, with a sensitivity of 59.0% and a specificity of 77.4%. In patients with hypercalciuria (>400 mg/24-hour) dUMg was positively correlated with dUCa in those without nephrolithiasis (r=0.50, β=0.2, P=0.002) but not in those with nephrolithiasis (r=0.05, β=0.014; P=0.8). In patients without hypercalciuria we found that hypomagnesuria remained a predictor of nephrolithiasis using either 400 mg/die (P=0.002, OR 5.12 (1.84–14.24) or 4 mg/kg bw (P=0.014, OR 6.24 (1.45–26.8). Moreover, the OR for nephrolithiasis improved using the combination of d-HypoMg with d-UCa>4 mg/kg (OR 8.12, CI 1.92–34.18, P=0.004), but not with dUCa> 400 mg/day. The current urinary calcium threshold of >400 mg/24-hour has a low sensitivity in detecting nephrolithiasis; our data suggest that sensitivity, specificity and positive predictive value could be improved including dUMg, dUCa/dUMg ratio and the combination of d-HypoMg with d-UCa>4 mg/kg in the stone risk evaluation.

Volume 63

21st European Congress of Endocrinology

Lyon, France
18 May 2019 - 21 May 2019

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.